Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;248(15):1319-1332.
doi: 10.1177/15353702231187646. Epub 2023 Sep 9.

Molecular and environmental contributors to neurological complications in sickle cell disease

Affiliations
Review

Molecular and environmental contributors to neurological complications in sickle cell disease

Kristine A Karkoska et al. Exp Biol Med (Maywood). 2023 Aug.

Abstract

Sickle cell disease (SCD) is an inherited hemoglobinopathy in which affected hemoglobin polymerizes under hypoxic conditions resulting in red cell distortion and chronic hemolytic anemia. SCD affects millions of people worldwide, primarily in Sub-Saharan Africa and the Indian subcontinent. Due to vaso-occlusion of sickled red cells within the microvasculature, SCD affects virtually every organ system and causes significant morbidity and early mortality. The neurological complications of SCD are particularly devastating and diverse, ranging from overt stroke to covert cerebral injury, including silent cerebral infarctions and blood vessel tortuosity. However, even individuals without evidence of neuroanatomical changes in brain imaging have evidence of cognitive deficits compared to matched healthy controls likely due to chronic cerebral hypoxemia and neuroinflammation. In this review, we first examined the biological contributors to SCD-related neurological complications and then discussed the equally important socioenvironmental contributors. We then discuss the evidence for neuroprotection from the two primary disease-modifying therapies, chronic monthly blood transfusions and hydroxyurea, and end with several experimental therapies designed to specifically target these complications.

Keywords: Sickle cell disease; cognitive decline; hemolytic anemia; hypoxemia; neuroinflammation; vasculopathy.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
The biological and environmental contributors to cognitive decline in sickle cell disease. Cognitive decline in individuals with sickle cell disease (SCD) is complex with diverse biological and environmental contributors. The biological components include chronic hemolytic anemia, cerebral hypoxemia, vasculopathy, including overt stroke and silent cerebral infarctions, and systemic and neuroinflammation. Societal and environmental components span from childhood household income, parental educational attainment, and chronic school absenteeism to a lack of funding for SCD research and societal implicit bias. As illustrated through the circular model, all of these contributors are interconnected and influence one another. Source: Created with BioRender.com.

References

    1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38:S512–21 - PubMed
    1. Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med 2013;10:e1001484 - PMC - PubMed
    1. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, Pegelow CH, Vichinsky E. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995;86:776–83 - PubMed
    1. Lubeck D, Agodoa I, Bhakta N, Danese M, Pappu K, Howard R, Gleeson M, Halperin M, Lanzkron S. Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease. JAMA Netw Open 2019;2:e1915374 - PMC - PubMed
    1. Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Jordan LB, Armstrong FD; The Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010;303:1823–31 - PMC - PubMed

Publication types